Alkermes (ALKS) Change in Acquisitions & Divestments (2010 - 2026)

Alkermes (ALKS) reported Change in Acquisitions & Divestments of $42.6 million for Q1 2026, down 62.46% year-over-year from $113.5 million in Q1 2025, and down 88.7% quarter-over-quarter from $377.1 million in Q4 2025.

Alkermes (ALKS) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has 17 years of Change in Acquisitions & Divestments data on file, last reported at $42.6 million in Q1 2026.

  • Change in Acquisitions & Divestments for Q1 2026 came in at $42.6 million, down 62.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $626.6 million (up 83.6% YoY), and the FY2025 annual result was $697.5 million, up 124.79% from the prior year.
  • Change in Acquisitions & Divestments slipped to $42.6 million in Q1 2026 per ALKS's latest filing, from $377.1 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $377.1 million in Q4 2025 and troughed at $42.6 million in Q1 2026.
  • A 5-year average of $99.3 million and a median of $82.5 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
  • The sharpest annual moves came in 2025 and 2026: Change in Acquisitions & Divestments soared 341.06% in 2025, then slumped 62.46% in 2026.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $90.6 million in 2022, then dropped by 29.85% to $63.6 million in 2023, then surged by 34.48% to $85.5 million in 2024, then jumped by 341.06% to $377.1 million in 2025, then slumped by 88.7% to $42.6 million in 2026.
  • Business Quant data shows ALKS's Change in Acquisitions & Divestments at $42.6 million in Q1 2026, $377.1 million in Q4 2025, and $125.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 42.61 Mn
Mar 31, 2026 42.61 Mn
Dec 31, 2025 377.11 Mn
Dec 31, 2025 377.11 Mn
Sep 30, 2025 125.31 Mn
Sep 30, 2025 125.31 Mn
Jun 30, 2025 81.59 Mn
Jun 30, 2025 81.59 Mn
Mar 31, 2025 113.49 Mn
Mar 31, 2025 113.49 Mn
Dec 31, 2024 85.50 Mn
Dec 31, 2024 85.50 Mn
Sep 30, 2024 85.84 Mn
Sep 30, 2024 85.84 Mn
Jun 30, 2024 56.46 Mn
Jun 30, 2024 56.46 Mn
Mar 31, 2024 82.49 Mn
Mar 31, 2024 82.49 Mn
Dec 31, 2023 63.58 Mn
Dec 31, 2023 63.58 Mn